Complement C5 Activity Assay

To help researchers obtain reliable, interpretable, and project-specific data, Creative Biolabs provides customized complement C5 activity assay services for evaluating C5 functional activity in serum, plasma, purified protein systems, cell-based models, and inhibitor-treated experimental settings.

Submit Your Request Now

Download our service brochure

Inquiry

What is the Complement C5 Activity Assay?

The complement C5 activity assay is a functional testing service used to evaluate the activity, integrity, and downstream biological effects of complement C5. The assay can be designed to determine whether C5 in a sample can be cleaved by C5 convertase, generate bioactive C5a, initiate C5b-dependent terminal complex assembly, or support complement-mediated hemolysis or cytotoxicity. Depending on the assay format, C5 activity may be reflected by hemolytic readouts, C5a levels, C5b-9 formation, target cell lysis, deposition intensity, or inhibition curves.

Creative Biolabs provides C5 activity testing services using multiple assay formats. For classical terminal pathway activity, hemolytic assays can be applied to evaluate whether the sample supports C5-dependent lysis after upstream complement activation. For mechanistic or inhibitor studies, C5 cleavage assays and C5a/C5b-9 quantification may be used to distinguish upstream activation from downstream terminal complex formation. For drug discovery projects, inhibitor titration assays can be established to measure the potency of anti-C5 antibodies, peptides, aptamers, small molecules, recombinant proteins, or engineered complement regulators.

Our C5 activity assays can be customized for different sample types, species backgrounds, experimental activators, complement pathways, target cells, controls, detection methods, and reporting formats. We can also integrate C5 functional testing with other complement assays, such as CH50, AP50, C3 activity assays, C5a quantification, C5b-9 deposition assays, complement inhibitor validation, and cell-based complement activity assays, to generate a more complete view of complement function.

Great Minds Choose Creative Biolabs

Partner with Us

Service Portfolio

Creative Biolabs provides a flexible and comprehensive complement C5 activity assay service that can be tailored according to the research objective, sample availability, assay sensitivity requirements, and downstream data application.

C5 Hemolytic Activity Assay

Creative Biolabs can design hemolytic C5 assays using appropriate positive controls, negative controls, complement-depleted serum, reconstitution strategies, inhibitor-treated groups, and concentration gradients. This approach is suitable for C5 functional screening, lot-to-lot comparison, terminal pathway analysis, and anti-C5 inhibitor evaluation.

C5 Reconstitution Assay

For projects requiring precise confirmation of C5 function, Creative Biolabs can perform C5 reconstitution assays using C5-depleted systems. This assay is especially useful for studying C5 variants, recombinant C5 preparations, C5 stability, activity recovery, and functional differences between sample groups.

C5 Cleavage Assay

Creative Biolabs offers C5 cleavage assay services to evaluate whether C5 can be processed into C5a and C5b under specific experimental conditions. The assay can be configured with defined activators, convertase-generating systems, purified complement components, serum samples, or inhibitor-treated reactions.

C5a Generation Assay

Creative Biolabs provides C5a generation assays to quantify the production of C5a in biological samples or experimental reaction systems. C5a levels can be detected using ELISA, chemiluminescent immunoassays, multiplex platforms, or other suitable immunodetection methods.

C5b and Terminal Complex Formation Assay

Creative Biolabs provides C5b- and C5b-9-related functional assays to evaluate whether the tested system supports terminal complex formation. Depending on the project objective, we can measure soluble C5b-9, surface-deposited C5b-9, target cell membrane deposition, or downstream lytic activity.

C5 Inhibitor Validation Assay

Creative Biolabs provides C5 inhibitor validation services for evaluating the activity of anti-C5 antibodies, antibody fragments, peptides, aptamers, small molecules, fusion proteins, nanobodies, and other complement-modulating candidates.

C5 Activity Assay for Mutant or Engineered C5 Proteins

Creative Biolabs supports functional testing of purified or recombinant C5 proteins, including mutant C5, engineered C5 variants, species-specific C5 proteins, and C5 proteins exposed to different storage or formulation conditions. Activity assays can be designed to assess cleavage susceptibility, hemolytic restoration capability, C5a generation, C5b-9 formation, and interaction with inhibitors or regulatory molecules.

Cell-Based C5 Activity Assay

Cell-based complement activity assays provide biologically relevant information about complement-mediated effects on target cells. Creative Biolabs can develop cell-based C5 activity assays using appropriate target cell lines, primary cells, erythrocytes, endothelial cell models, immune cell systems, or disease-relevant cell platforms.

Customized C5 Activity Testing Panel

Creative Biolabs can develop customized C5 activity testing panels that combine multiple readouts, such as hemolysis, C5a generation, C5b-9 deposition, CH50, AP50, C3 activation, C5 convertase activity, and inhibitor response.

Discuss Your Needs

Assay Methods Available at Creative Biolabs

Creative Biolabs offers multiple technologies for complement C5 activity assay development. The final method is selected based on sensitivity, specificity, sample matrix, throughput, assay purpose, and reporting needs.

Hemolysis-Based Detection

ELISA-Based Detection

Flow Cytometry-Based Detection

Multiplex Assay Integration

Workflow of Complement C5 Activity Assay

Creative Biolabs provides an efficient and customized workflow for complement C5 activity assay services. The general workflow includes the following steps.

Complement C5 assay. (Creative Biolabs Original) Fig. 1 Workflow of complement C5 functional test.

Design Your Workflow

Key Readouts for C5 Activity Evaluation

Creative Biolabs can provide multiple readouts for complement C5 activity assay services. The selection of readouts depends on the biological question, sample type, assay format, and expected downstream application.

Hemolysis Percentage

It provides a direct indication of whether C5-dependent terminal pathway activation leads to membrane damage and target cell lysis. This readout is especially useful for evaluating serum complement activity, terminal pathway integrity, and anti-C5 inhibitory effects.

C5a Generation

C5a is a potent inflammatory mediator generated during C5 cleavage. Measurement of C5a provides information about C5 activation and inflammatory complement output. This readout is useful for disease mechanism studies, pharmacodynamic monitoring, inhibitor validation, and inflammatory biomarker analysis.

C5 Cleavage Status

Direct or indirect analysis of C5 cleavage can help determine whether C5 is processed under defined assay conditions. This readout is useful for studying C5 convertase activity, cleavage-resistant C5 variants, anti-C5 inhibitors, and mechanism-of-action studies.

C5b-9 Formation

Detection of soluble or surface-bound C5b-9 helps determine whether C5 activation proceeds to terminal complex assembly. This readout is useful for terminal pathway studies, cytotoxicity assays, and complement-mediated tissue injury models.

Recommended Assay Selection Guide

Creative Biolabs can recommend appropriate C5 activity assay formats based on the purpose of the study.

Study	Recommended Assay
For general functional assessment of serum C5 activity	Hemolytic assays or terminal pathway assays
For anti-C5 inhibitor validation, hemolysis inhibition	C5a generation inhibition, C5 cleavage inhibition, and C5b-9 suppression assays
For recombinant C5 or mutant C5 characterization	C5-depleted reconstitution assays and cleavage assays
For inflammatory pathway studies	C5a generation assays
For terminal complement pathway research	C5b-9 formation and deposition assays
For biologically relevant cytotoxicity evaluation	Cell-based complement assays
For complex mechanism studies	A multi-readout panel combining C5a, C5b-9, hemolysis, and pathway-specific assays

Design Your Customization

Case Studies

Case 1

A macrocyclic peptide inhibitor of human complement component 5 uses a dual mode of action to prevent terminal complement pathway activation

C5a and sC5b9 (soluble MAC) levels in supernatants from the CP-mediated hemolysis assay were quantified using complement kits. Of the supernatant in the sample diluent, the C5a ELISA was performed at 1:5 dilution, and the sC5b9 ELISA was performed at 1:2 dilution. Data were converted to a percentage of C5a or sC5b9 production inhibition and fitted to a standard four-parameter dose-response inhibition function to calculate IC50 values.

C5a and sC5b9. (OA Literature) Fig. 2 ELISA measurement of C5a and sC5b9.^1,3

Case 2

Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models

In previous work, the researchers developed a model system to form purified alternative pathway (AP) C5 convertases on C3b-coated beads and quantify C5 conversion via functional analysis of released C5a. Then, they developed a C3aR cell reporter system that enables functional discrimination between C3 and C5 convertases. By regulating the C3b density on the bead surface, they observed that high C3b densities are important for conversion of C5, but not C3, by AP convertases. Screening of well-characterized complement-binding molecules revealed that differential inhibition of AP C3 convertases (C3bBb) and C5 convertases [C3bBb(C3b)n] is possible.

Fig. 3 The effect of inhibitors on classical pathway C3 and C5 conversion.^2,3

References

Tang, Guo-Qing, et al. "Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation." Frontiers in immunology 14 (2023): 1213920. https://doi.org/10.3389/fimmu.2023.1213920
Zwarthoff, Seline A., et al. "Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models." Frontiers in immunology 9 (2018): 1691. https://doi.org/10.3389/fimmu.2018.01691
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We appreciated the communication during the entire assay development process. The team explained the assay options, clarified sample requirements, and provided updates when optimization was needed. The service was scientifically sound and project-oriented."

— Research Manager, Biotechnology Company

"We initially requested C5 activity testing, but the Creative Biolabs team recommended combining it with additional complement activation markers to clarify whether the observed effect was C5-specific or caused by upstream pathway changes. This integrated strategy helped us better understand the mechanism behind our results."

— Principal Investigator, Translational Complement Research Laboratory

"Our project required validation of several anti-C5 molecules using functional complement readouts. Creative Biolabs developed dose-response assays and provided inhibition curves with clear data interpretation. The results were useful for ranking candidates and selecting molecules for further development."

— Project Manager, Biopharmaceutical R&D Team

"Our team was developing a C5-targeting inhibitor and needed more than a simple binding assay to understand whether our candidate could truly block complement function. Creative Biolabs designed a C5 activity assay that incorporated hemolysis, C5a generation, and C5b-9 formation readouts. The multi-readout strategy gave us clear functional evidence and helped us compare lead candidates with confidence."

— Scientist, Complement Therapeutics Discovery Program

Frequently Asked Questions

Can Creative Biolabs customize the assay for my project?

Yes. Creative Biolabs provides customized complement C5 activity assay development according to the sample matrix, species, candidate molecule, assay purpose, readout preference, throughput requirement, and available sample volume. Assay conditions such as activation method, sample dilution, incubation time, target cell type, inhibitor concentration range, detection platform, and control design can be optimized to meet project-specific requirements.

How should serum samples be collected and stored?

Serum samples should generally be processed promptly after collection, aliquoted to avoid repeated freeze-thaw cycles, and stored at low temperature until testing. Improper handling may cause artificial complement activation or loss of functional activity. Hemolyzed, contaminated, repeatedly thawed, or poorly stored samples may affect assay performance. Creative Biolabs can provide assay-specific sample preparation instructions before project initiation.

Can Creative Biolabs test C5 activity in animal models?

Yes. Creative Biolabs supports C5 activity testing for human samples and multiple animal species, including mouse, rat, rabbit, guinea pig, non-human primate, and other model organisms. Species-specific feasibility depends on complement biology, reagent availability, assay format, and sample matrix. For less common species, assay development or feasibility testing may be recommended.

Can the assay measure C5a and C5b-9 at the same time?

Yes. Creative Biolabs can design multi-readout C5 activity assays that include C5a generation and C5b-9 formation in the same study. This is useful because C5a and C5b-9 represent different downstream consequences of C5 activation. Measuring both readouts can provide a more complete understanding of inflammatory signaling and terminal pathway activation.

Is hemolysis always required for C5 activity testing?

No. Hemolysis is a common functional readout for terminal pathway activity, but it is not the only option. C5 activity can also be evaluated through C5 cleavage, C5a generation, C5b-9 formation, surface deposition assays, flow cytometry, fluorescence-based cell lysis assays, immunoassays, and cell-based functional readouts. For samples or applications where hemolysis is not suitable, Creative Biolabs can recommend alternative assay formats.

What controls are included in the assay?

Control design depends on the assay format, but common controls may include normal serum controls, heat-inactivated serum controls, blank controls, matrix controls, C5-depleted serum controls, reconstitution controls, pathway activation controls, inhibitor-treated controls, positive inhibition controls, and untreated baseline controls. Proper controls are essential for confirming assay validity and interpreting C5-specific activity.